The iRGD-induced tumour-to-blood transport of AFP was found to depend on neuropilin-1 and on the concentration gradient between the tumour and the blood, and was primarily seen in animals with small tumours and basally normal blood AFP levels. This evidence concerns the gene AFP and neoplasm.